Please ensure Javascript is enabled for purposes of website accessibility
Home / News / St. Charles Business Record / Glaxo ordered to pay $2.5 million for Paxil defects

Glaxo ordered to pay $2.5 million for Paxil defects

GlaxoSmithKline Plc must pay $2.5 million over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial. Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxil's ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*